Literature DB >> 5454342

Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.

K V Rao, D A Mitchison, N G Nair, K Prema, S P Tripathy.   

Abstract

Sulphadimidine acetylation studies were undertaken in 103 patients, 52 of whom had been classified as slow and 51 as rapid inactivators of isoniazid by a standard microbiological assay method. Each patient received sulphadimidine by mouth in a dose of 44 mg./kg. body weight, and free and total sulphadimidine were estimated in blood and urine collected at six hours. The findings suggest that patients may be classified as slow inactivators of isoniazid if the proportion of acetylated sulphadimidine (total minus free) is (a) less than 25% in blood or (b) less than 70% in urine. The sulphadimidine test is easy to perform and the result is available the same day; urine specimens for the test can be stored at room temperature for over a week without any loss of drug.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5454342      PMCID: PMC1701336          DOI: 10.1136/bmj.3.5721.495

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  A NEW METHOD FOR THE DETERMINATION OF N-ACETYL ISONIAZID IN URINE OF AMBULATORY PATIENTS.

Authors:  L EIDUS; E J HAMILTON
Journal:  Am Rev Respir Dis       Date:  1964-04

3.  Genetical and geographic studies on isoniazid inactivation.

Authors:  S SUNAHARA
Journal:  Science       Date:  1961-11-10       Impact factor: 47.728

4.  Deterioration of isoniazid in frozen serum samples: a confirmatory note.

Authors:  J W JENNE
Journal:  Am Rev Respir Dis       Date:  1961-06

5.  Stability of isoniazid in aqueous solutions and plasma.

Authors:  N F POOLE; A E MEYER
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

6.  Studies of human patterns of isoniazid metabolism using an intravenous fall-off technique with a chemical method.

Authors:  J W JENNE
Journal:  Am Rev Respir Dis       Date:  1960-01

7.  Madras study of supervised once-weekly chemotherapy.

Authors:  N K Menon
Journal:  Bull Int Union Tuberc       Date:  1968-12

8.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

9.  Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man.

Authors:  J H Peters; K S Miller; P Brown
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

10.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.

Authors:  J B SELKON; W FOX; P R GANGADHARAM; K RAMACHANDRAN; C V RAMAKRISHNAN; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

View more
  23 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).

Authors:  L H Jeyakumar; U A Arowoshegbe; O O Akinyinka; F O Akinbami; E A Bababunmi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

3.  Intersubject variability of sulphadimidine acetylation in student volunteers [proceedings].

Authors:  D K Liscombe; P J Nicholls
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

4.  Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  Lowering of theophylline clearance by isoniazid in slow and rapid acetylators.

Authors:  B Santoso
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

6.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

7.  Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.

Authors:  J Singh; A Arora; P K Garg; V S Thakur; J N Pande; R K Tandon
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

8.  Effects of salbutamol on the absorption and disposition of sulphamethoxazole in adult volunteers.

Authors:  G I Adebayo; T O Ogundipe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

9.  Polymorphic acetylation of sulphadimidine in normal and uraemic man.

Authors:  T Talseth; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

10.  [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].

Authors:  E Musch; M Eichelbaum; J K Wang; W von Sassen; M Castro-Parra; H J Dengler
Journal:  Klin Wochenschr       Date:  1982-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.